Patient Portal

Login

COVID Vaccination and Myeloproliferative Neoplasms
COVID Vaccine effectiveness data for MPN's now available
Datopotamab Deruxtecan Promising in Triple Negative Breast Cancer
Datopotamab Deruxtecan Promising in Triple Negative Breast Cancer
Cryoablation Emerging as Effective Treatment for Low Risk Breast Cancers
Could freezing temperatures be the next treatment for breast cancer?
Jakafi Rechallenge May Improve Survival in Patients with Myelofibrosis
Using Jakafi a second time may benefit patients with Myelofibrosis.
A High-Fiber Diet Does Not Reduce Risk for Colorectal Cancer
A High-Fiber Diet Does Not Reduce Risk for Colorectal Cancer
Zynlonta (loncastuximab tesirine) ADC for Non-Hodgkin Lymphoma
FDA grants accelerated approval to Zynlonta, a novel Anitbody Drug Conjugate for the treatment relapsed/refractory large B-cell lymphoma
Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer Reduces Recurrence Risk
Low dose Xeloda reduces the risk of TNBC recurrence
Diets Low in Fruits, Vegetables and Fiber May Increase Colon Cancer Risk
Diets Low in Fruits, Vegetables and Fiber May Increase Colon Cancer Risk
Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic Leukemia
Imbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
P-Selectin (SELP) and Glioblastoma
Research Breakthrough - Activating the brain's immune system against cancer prevents it from spreading .